STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provi…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO Inspired about the potential of medical cannabis when prescribed by doctors to patients in pain, Hans Wittrup, M.D., Ph.
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“Stenocare”) has selected an international, highly experienced partner to produce a new and innovative medical cannabis oil product, t…
Marknaden för medicinsk cannabis har stor tillväxtpotential när land för land överväger legaliseringen ute i Europa. Utmaningen är att bemöta de missuppfattningar om läkemedlet som fortfarande finns. – Det är bara en frå…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provi…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("Stenocare") meddelade den 15 maj 2023 att bolaget kommer att ta in upp till 30 miljoner DDK i en företrädesemission med Units på Nas…
15 May 2023 | Stenocare A/S | Company announcement | Inside Information NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KON…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“Stenocare”) announced on October 28, 2022, that it would enter Norway with prescription-based medical cannabis oil products. At the e…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“Stenocare”) announced October 14, 2022, that it had received approval to supply a new CBD 20 mg/mL medical cannabis oil product to…
Danska Stenocare, som är verksamma inom medicinsk cannabis, redovisar ett ebita-resultat för det tredje kvartalet 2022 på -4,3 miljoner danska kronor (-3,0). .
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“Stenocare”) now enters its 5th market. Stenocare has distribution agreement with the leading distributor and pharmacy chain in Norway…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) hereby announces that it has received approval from The Danish Medicines Agency to sell a new CBD medical cannabis oil pr…
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S (“Stenocare”) today announces groundbreaking results from their study of a new medical cannabis oil formulation. The study shows that th…
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO After securing market access and approvals in both Denmark, Sweden and UK, STENOCARE A/S (“Stenocare”) now takes a first and firm footstep into the southern hemisp…
De tre produkterna har sitt ursprung från Stenocares leverantör i Kanada och kommer att göras tillgängliga för brittiska patienter inom 60-90 dagar. Det framgår av ett pressmeddelande.
”Storbritannien är den tredje störs…